DekaBank Deutsche Girozentrale
AGN

DekaBank Deutsche Girozentrale’s Allergan Inc AGN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-41,305
Closed -$8.8M – 1203
2014
Q4 		$8.8M Buy
41,305
+2,754
+7% +$548K 0.11% 190
2014
Q3 		$6.91M Buy
38,551
+7,612
+25% +$1.26M 0.09% 219
2014
Q2 		$5.38M Sell
30,939
-7,285
-19% -$1.13M 0.08% 256
2014
Q1 		$4.68M Sell
38,224
-1,829
-5% -$223K 0.07% 261
2013
Q4 		$4.43M Sell
40,053
-37,499
-48% -$3.58M 0.07% 217
2013
Q3 		$7.04M Buy
77,552
+32,651
+73% +$2.93M 0.12% 151
2013
Q2 		$3.84M Buy
+44,901
New +$4.66M 0.08% 202

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AGN Position: Q1 2015 in Review

DekaBank Deutsche Girozentrale sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 41,305 shares — an estimated $8.8M sold.

DekaBank Deutsche Girozentrale first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $8.8M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • DekaBank Deutsche Girozentrale reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 41,305 Allergan Inc shares in Q1 2015, an estimated $8.8M.
  • DekaBank Deutsche Girozentrale first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • DekaBank Deutsche Girozentrale's Allergan Inc position peaked at $8.8M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2015, filed 5 May 2015.